Document Type and Number:
Japanese Patent JPWO2021177390
Kind Code:
A1
Abstract:
A compound according to the present invention has a chemical structure which, when viewed macroscopically, is arranged such that a chelating portion is positioned in the center of the structure, an atomic group containing an albumin binding site is bonded to one side of the chelating portion, and an atomic group containing a target molecule binding site is bonded to the other side of the chelating portion. The chelating portion is preferably DOTA or a derivative thereof. The target molecule binding site preferably has a structure which binds to a target molecule expressed in cancer tissue. In addition, the present invention provides a radioactive labeling compound in which the aforementioned compound is coordinated with a radioactive metal ion.
Application Number:
JP2022504449A
Publication Date:
September 10, 2021
Filing Date:
March 04, 2021
Export Citation:
Previous Patent: JPWO2021177389
Next Patent: Group-based communication systems and devices configured to manage channel titles associated with ch...
Next Patent: Group-based communication systems and devices configured to manage channel titles associated with ch...